Evidence map›Paper›PMID 26279676›Full record

ArticleBiotechnology for biofuels2015

Insertion of a xylanase in xylose binding protein results in a xylose-stimulated xylanase.

Lucas Ferreira Ribeiro, Nathan Nicholes, Jennifer Tullman, Liliane Fraga Costa Ribeiro, Carlos Alessandro Fuzo, Davi Serradella Vieira, Gilvan Pessoa Furtado, Marc Ostermeier, Richard John Ward

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Engineering Allostery into Proteins.Advances in experimental medicine and biology · 2019
    Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Lucas Ferreira RibeiroJohns Hopkins University, Baltimore, MD USA ; Departamento de Bioquímica e Imunologia, FMRP, Universidade de São Paulo-USP, Ribeirão Preto, SP Brazil.
Nathan NicholesJohns Hopkins University, Baltimore, MD USA.
Jennifer TullmanInstitute for Bioscience and Biotechnology Research, Rockville, MD USA.
Liliane Fraga Costa RibeiroDepartamento de Bioquímica e Imunologia, FMRP, Universidade de São Paulo-USP, Ribeirão Preto, SP Brazil ; University of Maryland Baltimore County-UMBC, Baltimore, MD USA.
Carlos Alessandro FuzoDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo-USP, Av. Bandeirantes, 3900, Ribeirão Preto, SP 14040-901 Brazil.
Davi Serradella VieiraUniversidade Federal do Rio Grande do Norte, Natal, Brazil.
Gilvan Pessoa FurtadoDepartamento de Bioquímica e Imunologia, FMRP, Universidade de São Paulo-USP, Ribeirão Preto, SP Brazil.
Marc OstermeierJohns Hopkins University, Baltimore, MD USA.
Richard John WardBrazilian Bioethanol Science and Technology Laboratory CTBE/CNPEM, Campinas, Brazil ; Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo-USP, Av. Bandeirantes, 3900, Ribeirão Preto, SP 14040-901 Brazil.
Universidade de São Paulo · BRJohns Hopkins University · USInstitute for Bioscience and Biotechnology ResearchUniversidade de Ribeirão Preto · BRUniversidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProduct inhibition can reduce catalytic performance of enzymes used for biofuel production. Different mechanisms can cause this inhibition and, in most cases, the use of classical enzymology approach is not sufficient to overcome this problem. Here we have used a semi-rational protein fusion strategy to create a product-stimulated enzyme.

resultsA semi-rational protein fusion strategy was used to create a protein fusion library where the Bacillus subtilis GH11 xylanase A (XynA) was inserted at 144 surface positions of the Escherichia coli xylose binding protein (XBP). Two XynA insertions at XBP positions 209 ([209]XBP-Xyn-XBP) and 262 ([262]XBP-Xyn-XBP) showed a 20% increased xylanolytic activity in the presence of xylose, conditions where native XynA is inhibited. Random linkers of 1-4 Gly/Ala residues were inserted at the XynA N- and C-termini in the [209]XBP and [262]XBP, and the chimeras 2091A and 2621B were isolated, showing a twofold increased xylanolytic activity in the presence of xylose and k cat values of 200 and 240 s(-1) in the 2091A and 2621B, respectively, as compared to 70 s(-1) in the native XynA. The xylose affinity of the XBP was unchanged in the chimeras, showing that the ~3- to 3.5-fold stimulation of catalytic efficiency by xylose was the result of allosteric coupling between the XBP and XynA domains. Molecular dynamics simulations of the chimeras suggested conformation alterations in the XynA on xylose binding to the XBP resulted in exposure of the catalytic cavity and increased mobility of catalytic site residues as compared to the native XynA.

conclusionsThese results are the first report of engineered glycosyl hydrolase showing allosteric product stimulation and suggest that the strategy may be more widely employed to overcome enzyme product inhibition and to improve catalytic performance. Graphical abstractProtein fusion of a GH11 xylanase (in red) and a xylose binding protein (XBP, in blue) results in a xylanase-XBP chimera that presents allosteric activation of the xylanase activity by xylose (shown as a space-filled molecule bound to the xylanase-XBP chimera).

Indexed as

Enzyme engineeringHeterotropic allosteric regulationNon-homologous genesSemi-rational design

Identifiers

PMID26279676
PMCPMC4536891
OpenAlexW1798639337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.